Albireo
Quick facts
Marketed products
- Questran · Other
Phase 3 pipeline
- A4250 (odevixibat) · Hepatology / Gastroenterology
Odevixibat inhibits the ileal bile acid transporter (IBAT) to reduce bile acid reabsorption and increase fecal excretion, thereby lowering serum bile acids.
Phase 2 pipeline
- A3309 · Gastroenterology / Metabolic disease
A3309 is a bile acid sequestrant that binds bile acids in the intestine to increase their fecal excretion and modulate metabolic pathways. - A3384
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: